You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 412 First-in-human phase I/IIa trial to evaluate the safety and initial clinical activity of DuoBody®-PD-L1×4–1BB (GEN1046) in patients with advanced solid tumors

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials in progress
412 First-in-human phase I/IIa trial to evaluate the safety and initial clinical activity of DuoBody®-PD-L1×4–1BB (GEN1046) in patients with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020598062
Dec 202059020
Jan 2021160033
Feb 2021184057
Mar 2021288055
Apr 2021266072
May 202183049
Jun 20210046
Jul 20210040
Aug 20210071
Sep 20210048
Oct 2021346066
Nov 2021683096
Dec 2021508073
Jan 2022370056
Feb 2022180036
Mar 2022408047
Apr 2022484076
May 2022420087
Jun 2022302043
Jul 2022236022
Aug 2022324025
Sep 2022260024
Oct 2022318033
Nov 2022328036
Dec 2022220024
Jan 2023288032
Feb 2023350031
Mar 2023330039
Apr 2023214038
May 2023332037
Jun 2023344051
Jul 2023336034
Aug 2023358037
Sep 2023532032
Oct 2023474038
Nov 2023460033
Dec 2023292023
Jan 202460011
Feb 2024232016
Mar 2024376049
Apr 2024264030
May 2024292022
Jun 2024188024
Jul 2024304022
Aug 2024238015
Sep 2024254012
Oct 2024306022
Nov 2024352022
Dec 2024268014
Jan 2025230030
Feb 202552013
Mar 20250014
Apr 20250012
May 20250010
Jun 20251011
Total1475202071